Company: MDCXW
Filing Date: 2025-12-01
Form Type: 8-K
Source: 0001062993-25-017085
Chunk: 0

Company: Medicus Pharma Ltd.
Filing Date: 2025-12-01
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01 Regulation FD Disclosure.

A press release announcing Mr. Quinlan's resignation and Ms. Bonner's appointment, described in Item 5.02 herein, is attached as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 7.01 and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference in any registration statement filed under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated by reference therein.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit      Description                                                            
      No.                                                                             
     99.1      Press Release, dated December 1, 2025.                                 
 ──────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (formatted as Inline XBRL document).  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

  MEDICUS PHARMA LTD.                                                      
  By:                      /s/ Raza Bokhari                                
  Name:                    Dr. Raza Bokhari                                
  Title:                   Executive Chairman and Chief Executive Officer  

Dated: December 1, 2025